论文部分内容阅读
本文报告和分析了近年来我们对肝癌病人免疫功能检测的结果。一、检测对象和方法: 对象是1981～1982年我附属一院门诊和住院收治的病人共56例。男50例,女6例。年龄19～79岁。根据1977年全国肝癌防治研究协作会议提出的诊断标准,诊断为Ⅱ期或Ⅲ期原发性肝细胞癌53例,胆管细胞癌3例。随机抽取同期内科非肿瘤病人409例作对照。各项检测正常对照值参考我附属一院中心实验室的正常值。二、检测项目和结果: 1.PHA皮肤试验:皮肤反应直径最小为0,平均0.9±0.2cm。非肿瘤病对照组平均1.3±0.1cm,t=1.986,0。05>P>0.01。正常对照值是1.5cm以上,与肝癌比较,t=3.061,P<0.005。
This article reports and analyzes the results of our recent tests of immune function in patients with liver cancer. First, the test objects and methods: The object is from 1981 to 1982, I was affiliated with a hospital outpatient and inpatient treatment of a total of 56 cases. 50 males and 6 females. Age 19 to 79 years old. According to the diagnostic criteria proposed by the National Collaborative Meeting for the Prevention and Treatment of Liver Cancer in 1977, 53 patients with stage II or III primary hepatocellular carcinoma and 3 patients with cholangiocarcinoma were diagnosed. Randomly selected 409 non-cancer patients in the same period as controls. The normal control values for each test were based on the normal values of the central laboratory of the attached hospital. Second, the test items and results: 1. PHA skin test: The skin reaction minimum diameter of 0, an average of 0.9 ± 0.2cm. The non-tumor disease control group averaged 1.3±0.1 cm, t=1.986, 0.05, and P>0.01. The normal control value was 1.5 cm or more, compared with liver cancer, t=3.061, P<0.005.